Clinical outcome following therapeutic vaccination with autologous mRNA electroporated dendritic cell (DC) vaccines in patients with advanced melanoma.

Sofie Wilgenhof,A. M. T. Van Nuffel,Daphné Benteyn,Jurgen Corthals,Carlo Heirman,L. Pierret,A. De Coninck,Aude Bonehill,Kris Thielemans,Bart Neyns

Clinical outcome following therapeutic vaccination with autologous mRNA electroporated dendritic cell (DC) vaccines in patients with advanced melanoma.

2010

Sofie Wilgenhof
A. M. T. Van Nuffel
Daphné Benteyn
Jurgen Corthals
Carlo Heirman
L. Pierret
A. De Coninck
Aude Bonehill
Kris Thielemans
Bart Neyns

8547 Background: mRNA electroporated autologous DC are being developed as therapeutic cancer vaccines. Potential advantages include the presentation of all potential tumor antigen confined epitopes...

Keywords:

Dendritic cell
Melanoma
Pathology
Immunology
Vaccination
Medicine
dc vaccine
in patient
Tumor antigen
Epitope
Cancer
Messenger RNA

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations